Free Account Opening + AMC Free Demat
Loading...

Eris Lifesciences IPO vs Tejas Networks IPO

Comparision between Eris Lifesciences IPO and Tejas Networks IPO.

IPO Details

Eris Lifesciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Tejas Networks IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Eris Lifesciences IPO is up to ₹1,741.16 Cr whereas the issue size of the Tejas Networks IPO is up to ₹776.69 Cr. The final issue price of Eris Lifesciences IPO is ₹603.00 per share and of Tejas Networks IPO is ₹257.00 per share.

  Eris Lifesciences IPO Tejas Networks IPO
Face Value ₹1 per share ₹10 per share
Issue Price (Lower) ₹600.00 per share ₹250.00 per share
Issue Price (Upper) ₹603.00 per share ₹257.00 per share
Issue Price (Final) ₹603.00 per share ₹257.00 per share
Discount (Retail)
Discount (Employee) ₹60.00 per share
Market Lot Size 24 shares 55 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹450.00 Cr
OFS Issue Size 2,88,75,000 shares 1,27,11,605 shares
OFS Issue Size (Amount)
Issue Size Total 2,88,75,000 shares 3,02,21,332 shares
Issue Size Total (Amount) up to ₹1,741.16 Cr up to ₹776.69 Cr

IPO Timetable

Eris Lifesciences IPO opens on Jun 16, 2017, while Tejas Networks IPO opens on Jun 14, 2017. The closing date of Eris Lifesciences IPO and Tejas Networks IPO is Jun 20, 2017, and Jun 16, 2017, respectively.

  Eris Lifesciences IPO Tejas Networks IPO
Anchor Bid Date
Issue Open Jun 16, 2017 Jun 14, 2017
Issue Close Jun 20, 2017 Jun 16, 2017
Basis Of Allotment (Tentative) Jun 23, 2017 Jun 21, 2017
Initiation of Refunds (Tentative) Jun 27, 2017 Jun 22, 2017
Credit of Share (Tentative) Jun 28, 2017 Jun 23, 2017
Listing date (Tentative) Jun 29, 2017 Jun 27, 2017
Anchor Lockin End date 1 Jul 23, 2017 Jul 21, 2017
Anchor Lockin End date 2 Sep 21, 2017 Sep 19, 2017

Financials

Eris Lifesciences IPO P/E ratio is , as compared to Tejas Networks IPO P/E ratio of .

  Eris Lifesciences IPO Tejas Networks IPO
Financial
Summary of financial Information (Consolidated)
Particulars For the year/period ended (in Rs. Million)
31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12
Total Assets 3,973.59 3,572.85 2,705.99 1,718.05 1,019.67
Total Revenue 5,970.21 5,455.58 5,088.22 3,930.64 2,739.40
Profit After Tax 1,348.58 892.59 709.12 584.40 370.63
Summary of financial Information (Consolidated)
Particulars For the year/period ended (in Rs. Million)
31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12
Total Assets 8,383.03 7,280.56 7,452.00 6,563.40 6,397.81
Total Revenue 6,274.57 3,868.26 4,230.55 3,692.71 2,014.22
Profit After Tax 290.05 (178.66) 27.77 (790.43) (928.90)
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Eris Lifesciences IPO retail investors (RII) are offered 28,72,500 shares while in Tejas Networks IPO retail investors are offered 28,72,500 shares. Qualified institutional buyers (QIB) are offered 86,17,500 shares in Eris Lifesciences IPO and 94,34,105 shares in Tejas Networks IPO.

  Eris Lifesciences IPO Tejas Networks IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 86,17,500 shares 94,34,105 shares
NII 43,08,750 shares 46,06,740 shares
RII 28,72,500 shares 30,71,160 shares
Employee 1,50,000 shares
Others
Total 1,59,48,750 shares 1,71,12,005 shares

Bids Received (Subscription)

Eris Lifesciences IPO subscribed 3.29x in total, whereas Tejas Networks IPO subscribed 1.88x.

  Eris Lifesciences IPO Tejas Networks IPO
QIB (times) 4.68x 2.16x
NII (times) 0.45x 0.48x
Big NII (times)
Small NII (times)
RII (times) 3.51x 3.10x
Employee (times) 0.86x
Other (times)
Total (times) 3.29x 1.88x

Comments

Add a public comment...